| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/12/2001 | CA2372715A1 Preventive or therapeutic drugs for diabetes |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/11/2001 | EP1090990A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090925A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090908A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase |
| 04/11/2001 | EP1090640A2 Insulin analog formulations |
| 04/11/2001 | EP1090636A1 High lipid diet |
| 04/11/2001 | EP1090634A1 Agents for reducing cholesterol and lipid uptake |
| 04/11/2001 | EP1090136A1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
| 04/11/2001 | EP1090116A2 Transgenic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
| 04/11/2001 | EP1090030A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
| 04/11/2001 | EP1090027A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/11/2001 | EP1090026A1 Diacylglycerol o-acyltransferase |
| 04/11/2001 | EP1090019A1 Adenosine derivatives |
| 04/11/2001 | EP1090014A1 Arylsulfonanilide phosphates |
| 04/11/2001 | EP1089996A1 Paroxetine methanesulfonate |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089744A2 Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin |
| 04/11/2001 | EP1089732A1 Compositions and methods for treating elevated blood cholesterol |
| 04/11/2001 | EP1089731A1 Compositions and methods for treating elevated blood cholesterol |
| 04/11/2001 | EP1089723A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 04/11/2001 | CN1291238A Process for obtaining of HMG-CO A reductase inhibitors of high purify |
| 04/11/2001 | CN1291196A Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 04/11/2001 | CN1291178A E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl) phenoxy] ethanol and pharmaceutical compositions thereof |
| 04/11/2001 | CN1290701A Flavone chromium and its producing method and use |
| 04/11/2001 | CN1064351C Substituted indanylidineacetylguanidine, process for their paraparation, their use as medicaments ofdiagonstic and medicaments containing them |
| 04/11/2001 | CN1064349C Novel tricyclic amide, its preparing method and medicinal composition |
| 04/11/2001 | CN1064252C Hypoglycemic high calcium granule |
| 04/11/2001 | CN1064236C Application of pyromeconic acid and heteroside (eigeron glucoside) in pharmacy |
| 04/10/2001 | US6214991 3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-n-acetic acid, ethyl ester for example; treating complications of diabetes mellitus, such as cataracts, retinopathy, nephropathy, and neuropathy |
| 04/10/2001 | US6214978 Antitumor and anticholesterol preparations containing a lipoteichoic acid from streptococcus |
| 04/10/2001 | US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia |
| 04/10/2001 | US6214877 Antidiabetic agents; modulator of glucose concentration |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
| 04/10/2001 | US6214861 Enzyme inhibitor; viricides |
| 04/10/2001 | US6214850 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 04/10/2001 | US6214848 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action for prophylaxis and treatment of diabetes; depressing diabetic hyperglycemia |
| 04/10/2001 | US6214844 Substituted imidazole compounds |
| 04/10/2001 | US6214795 Polypetides with amino acid sequences |
| 04/10/2001 | US6214357 Treatment of diabetes |
| 04/10/2001 | CA2180487C Water for medical treatment, production method thereof, and dialysis apparatus using water for medical treatment as dialysis liquid |
| 04/10/2001 | CA2133413C Indole derivatives as 5-ht1 antagonists |
| 04/10/2001 | CA2014695C Feed additive for cultivated fishes and feed for cultivated fishes |
| 04/05/2001 | WO2001023588A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023427A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/05/2001 | WO2001023408A1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023390A2 Azepinoindole derivatives, the production and use thereof |
| 04/05/2001 | WO2001023389A2 Certain alkylene diamine-substituted heterocycles |
| 04/05/2001 | WO2001023388A2 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001023387A2 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001023386A2 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | WO2001023383A1 Quinuclidine compounds and drugs containing the same as the active ingredient |
| 04/05/2001 | WO2001023381A1 Piperidine derivatives as reuptake inhibitors |
| 04/05/2001 | WO2001023377A2 Polymorphic salt |
| 04/05/2001 | WO2001023347A1 Novel aromatic compounds |
| 04/05/2001 | WO2001023064A1 Method and installation for setting in adsorbed state on a porous support active compounds contained in a product |
| 04/05/2001 | WO2001022998A1 Stable calcitriol solution for packaging in vials |
| 04/05/2001 | WO2001022991A1 Acth treatment of steroid- and statin-treated patients |
| 04/05/2001 | WO2001022987A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | WO2001022982A2 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 04/05/2001 | WO2001022981A1 Treatment of diabetic nephropathy and microalbuminuria |
| 04/05/2001 | WO2001022976A2 Combination of a statin and ex-vivo treated blood for treating artheroclerosis |
| 04/05/2001 | WO2001022953A2 Use of retigabin for treating neuropathic pain |
| 04/05/2001 | WO2001022837A1 Composition comprising casein protein and whey protein |
| 04/05/2001 | WO2001012602A8 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 04/05/2001 | WO2001008657A3 Personal care articles |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2001005397A8 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 04/05/2001 | WO2001002400A8 Fused imidazole compounds and remedies for diabetes mellitus |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000065027A3 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 04/05/2001 | WO2000061139A8 Anticonvulsant derivatives useful in reducing blood glucose levels |
| 04/05/2001 | WO2000060051A8 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000055343A3 Retrovirus producting cells utilizing a high multiplicity of transduction |
| 04/05/2001 | WO2000050090A3 Dry acid-chitosan complexes |
| 04/05/2001 | CA2659048A1 Use of retigabine for the treatment of neuropathic pain |
| 04/05/2001 | CA2388438A1 Stable calcitriol solution for packaging in vials |
| 04/05/2001 | CA2386092A1 Piperidine derivatives |
| 04/05/2001 | CA2386002A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | CA2386000A1 Treatment of diabetic nephropathy and microalbuminuria |
| 04/05/2001 | CA2385883A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2384731A1 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/05/2001 | CA2384265A1 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | CA2352194A1 Azepinoindole derivatives, the production and use thereof |
| 04/04/2001 | EP1088832A1 Highly resistant granular starch |
| 04/04/2001 | EP1088824A2 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 04/04/2001 | EP1088819A2 6-azauracil derivatives as thyroid receptor ligands |
| 04/04/2001 | EP1088556A1 Medicinal compositions containing fibroblast growth factor-related peptides |